Study Title | APEC1621N: NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) – Phase 2 Subprotocol of LOXO-292 in Patients With Tumors Harboring RET Gene Alterations |
---|---|
Protocol ID | APEC1621N |
Disease (Sub Disease) | All paediatric cancer types |
Diagnosis Stage | Relapsed/refractory |
Location | WA |
Sponsor | National Cancer Institute (NCI) |
Collaborators | Children's Oncology Group |
Links | https://clinicaltrials.gov/ct2/show/NCT04320888 |
Trial Status | Closed to Recruitment |
Trial Open Date | 17/04/2018 |
Trial Close Date | 01/12/2023 |
Sites | Perth Children's Hospital |
Study Type | Treatment |
Phase | Phase 2 |
Age Eligibility | 12 Months to 21 Years |
International registry ID's | NCT04320888 |